Bionify Bioscience (OPC) Private Limited
About Bionify Bioscience (OPC) Private Limited
Data last updated:
Bionify Bioscience (OPC) Private Limited is a one person company based in Nagpur, Maharashtra, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 25 May 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2022OPC383348.
The company has an authorised share capital of ₹20,000 and a paid-up capital of ₹20,000. It is led by director Divya Ramprakash Khandelwal.
Its latest financial statements are for the year ended 31 March 2023. The registered office is at Flat No 12 Block C Vandana Co – Op H Soc Canal Road, Nagpur, Maharashtra, India – 440010.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.93 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹15.04 Lakh (net margin 0.4%) and EBITDA of ₹23.68 Lakh (EBITDA margin 0.6%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No 12 Block C Vandana Co – Op H Soc Canal Road, Nagpur, Maharashtra, India – 440010
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Bionify Bioscience (OPC) Private Limited FY 2023 filings available
Bionify Bioscience (OPC) Private Limited reported revenue of ₹39.93 Cr (up 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Bionify Bioscience (OPC) Private Limited
Revenue rose 50% in the latest year. EBITDA fell 52% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Bionify Bioscience (OPC) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹23.68 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15.04 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Bionify Bioscience (OPC) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.6% | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bionify Bioscience are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Bionify Bioscience (OPC) Private Limited
Bionify Bioscience has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divya Ramprakash Khandelwal | Director | 25 May 2022 | 4 Years 4 Months | Current |
Peer Comparison of Bionify Bioscience (OPC) Private Limited
Bionify Bioscience (OPC) Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Oncology Care). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apollo-Amrish Oncology Services Private Limited | ₹49.9 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Chennai, Tamil Nadu, India |
| Kerudi Healthcare Private Limited | ₹43.72 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Bagalkot, Karnataka, India |
| Hope & Heal Cancer Hospital and Research Center Private Limited | ₹43.25 Cr (FY 2025) | •••• | •••• | 253.0% | •••• | Rajganj, West Bengal, India |
| Onecell Diagnostics India Private Limited | ₹41.91 Cr (FY 2025) | •••• | •••• | 95.0% | •••• | Pune, Maharashtra, India |
| Asian Institute of Oncology Private Limited | ₹41.46 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Bionify Bioscience (OPC) Private Limited this company | ₹39.93 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Nagpur, Maharashtra, India |
| Valentis Cancer Care Hospital Private Limited | ₹39.63 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Meerut, Uttar Pradesh, India |
| Prathima Cancer Hospital Private Limited | ₹38.89 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Warangal, Telangana, India |
| Carcinova Private Limited | ₹37.02 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Cuttack, Odisha, India |
| Cancer Centers of America Private Limited | ₹36.39 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | Hyderabad, Telangana, India |
| Suprex Healthcare Private Limited | ₹32.94 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Bionify Bioscience by revenue in the Healthcare industry (Oncology Care), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Bionify Bioscience (OPC) Private Limited
Bionify Bioscience (OPC) Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bionify Bioscience (OPC) Private Limited
Employment history and EPFO contributions of people linked to Bionify Bioscience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bionify Bioscience (OPC) Private Limited
Bionify Bioscience (OPC) Private Limited has 1 board change on record since 2022: 1 appointment. The latest: Divya Ramprakash Khandelwal was appointed as Director on 25 May 2022.
Credit Ratings, Litigation & Regulatory Alerts for Bionify Bioscience (OPC) Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bionify Bioscience (OPC) Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bionify Bioscience (OPC) Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bionify Bioscience (OPC) Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bionify Bioscience (OPC) Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bionify Bioscience (OPC) Private Limited
Bionify Bioscience is an active company based in Nagpur, Maharashtra, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 25 May 2022 (4+ years old) and is registered under CIN U51909MH2022OPC383348.
Bionify Bioscience reported revenue of ₹39.93 Cr for FY 2025 (up 50% YoY).
Bionify Bioscience has 1 current director:
- Divya Ramprakash Khandelwal - Director
Bionify Bioscience reported a net profit of ₹15.04 Lakh (net margin 0.4%) and EBITDA of ₹23.68 Lakh (EBITDA margin 0.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Bionify Bioscience is U51909MH2022OPC383348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bionify Bioscience was incorporated on 25 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Bionify Bioscience by revenue are Apollo-Amrish Oncology Services Private Limited, Kerudi Healthcare Private Limited, Hope & Heal Cancer Hospital and Research Center Private Limited, Onecell Diagnostics India Private Limited, Asian Institute of Oncology Private Limited and 5 more, all in the Healthcare industry (Oncology Care).
Divya Ramprakash Khandelwal was appointed as Director on 25 May 2022.
The registered office of Bionify Bioscience is at Flat No 12 Block C Vandana Co – Op H Soc Canal Road, Nagpur, Maharashtra, India – 440010.
Bionify Bioscience has an authorised share capital of ₹20,000 and a paid-up capital of ₹20,000.
Bionify Bioscience operates in the healthcare industry, in the oncology clinics and cancer treatment segment.